$BFLY

ROBBINS LARRY sold $20.6M of BFLY (indirect holdings)

ROBBINS LARRY sold 2,297,733 indirectly-held shares of Butterfly Network, Inc. (BFLY) at an average of $8.98 ($8.70–$9.54, $20.62M total) across 5 trades over 2026-08-13 to 2026-08-17.

Original reporting
SEC EDGAR · ROBBINS LARRY
Published Aug 17, 2026, 11:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 11:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BFLY
Neutral
medium confidence
Mentioned
$BFLY
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BFLYNeutralLow
01

Why it matters

Traders may reassess near-term sentiment around BFLY due to the transaction size ($20.62M) and the absence of a stated 10b5-1 plan, but there is no accompanying fundamental update in the text.

02

Market read

The only new information is the insider sale details (shares, price range, total value, and post-transaction holdings).

03

What to watch

The filing does not specify the reason for the sale, and it states no pre-arranged 10b5-1 plan, which can increase headline sensitivity without proving information content.

Relevance 7/10Novelty 4/10Timing: filed 2026-08-17, covering sales from 2026-08-13 to 2026-08-17

Background

This is an SEC Form 4 insider transaction for Butterfly Network, Inc. (BFLY) by director Larry Robbins, reported as an indirect holding sale.

Company-level read

Ticker impact

$BFLYNeutralMedium confidence
Context

Butterfly Network director Larry Robbins sold $20.62M of BFLY shares via an open-market sale across five trades at $8.6973 to $9.5418.

Expected impact

Near-term sentiment could soften, but follow-through is likely limited absent additional company-specific catalysts.

Evidence & confidence

Form 4 confirms transaction size and pricing range, yet the article provides no new operational, financial, or regulatory development for BFLY.

Market effects

No direct sector read-through beyond routine insider activity in medical imaging/diagnostics.

None indicated.

None indicated.

Counterpoint

A large indirect sale can reflect diversification or liquidity needs rather than negative expectations, especially when multiple trades are spread across days.

Key entities

  • Butterfly Network, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Larry Robbins

    Director who sold 2,297,733 shares indirectly in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QSIMed

2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private

Neuralink, a private brain-computer interface (BCI) company, successfully helped a patient with ALS communicate. Investors cannot buy Neuralink, but two public companies, Quantum-Si (QSI) and Butterfly Network (BFLY), are connected to the BCI field. QSI makes research tools and saw a 7x volume spike, while BFLY supplies ultrasound chips to BCI developers like Merge Labs and Bridge Neurotech.

$BFLYHigh

Why is Butterfly Network stock climbing today?

Butterfly Network (BFLY) stock rose 1.6% pre-market after Canaccord Genuity initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and AI capabilities. Analysts highlight new products and partnerships. The stock has seen positive analyst activity, with a consensus target of $11.40. Q3 earnings are due October 29.

$BFLYHigh

Evercore ISI initiates Butterfly Network stock with outperform rating

Evercore ISI initiated coverage on Butterfly Network (NYSE: BFLY) with an outperform rating and $15.00 price target, citing its ultrasound-on-chip technology and growth potential. The firm projects $550M+ revenue by 2030 and positive EBITDA by 2028. BFLY stock has risen 367% over the past year, trading at $9.15 with a $2.44B market cap. Q2 2026 results showed a smaller loss than expected but lower revenue. Needham also initiated coverage with a buy rating and $10.00 target.

$BFLYHighAI 8/10

Why is Butterfly Network stock surging today?

Butterfly Network (BFLY) stock rose 11.5% after Needham initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and Embedded business model. TD Cowen also has a Buy rating and $10 target. BFLY's Q3 revenue grew 39% YoY, with Embedded segment growth and expanding margins. The broader market had minimal impact on BFLY's surge.

$BFLYMed

Butterfly Network at Morgan Stanley conference: platform push widens reach

Butterfly Network (BFLY) presented its strategy at Morgan Stanley's conference, shifting from handheld ultrasound to a semiconductor imaging platform. The company reported 20% revenue growth, with $112M in last 12-month revenue, and highlighted partnerships like Midjourney. It aims to expand its addressable market to $250B through its Butterfly Embedded model. The company expects a fourth-generation chip in 2027 to improve image quality and challenge competitors. Management emphasized its strong

$BFLYMed

Butterfly Network (BFLY) Is Up 24.2% After Raising 2026 Guidance And Narrowing Losses - Has The Bull Case Changed?

Butterfly Network (BFLY) shares rose 24.2% after the company reported Q2 2026 revenue of $32.61M and a reduced net loss of $12.91M, and raised 2026 revenue guidance to $119M to $123M. The article cites improving losses and momentum in Embedded partnerships and enterprise point-of-care ultrasound, while noting ongoing cash burn and potential dilution risks.